2020-04-04 IFR Magazine

JefferiesûSVB Leerink and Piper SandlerûEXPECTû

TOûPRICEûTHEûSALEûOFûMûSHARESûATû53nû

AFTERûTHEûCLOSEûONû4UESDAYû!PRILû

4HEûTYPICALû53û)0/ûUNDERTAKESûSEVENûORûEIGHTû

DAYSûOFûMARKETINGûBUTûTHEûFEWûISSUERSûTHATûCANû

CURRENTLYûACCESSûTHEûFUNDINGûWINDOWûAREû

SEEKINGûTOûLIMITûMARKETûEXPOSUREûWHILEûTHEû

CORONAVIRUSûCONTINUESûTOûUNSETTLEûINVESTORS

"ANKSûAREûALSOûEMPLOYINGûVIDEOûANDû

TELECONFERENCINGûTECHNOLOGIESûTOûOVERCOMEû

THEIRûCURRENTûINABILITYûTOûHOLDûPHYSICALû

MEETINGSûWITHûINVESTORS

+EROSûISûALREADYûCOVEREDûWITHûINSIDERûSUPPORTû

BANKERSûSAIDû"UTûUNLIKEûMANYûRECENTûBIOTECHû

)0/SûTHEREûISûNOûOFlCIALûINDICATIONûOFûINSIDERû

INTERESTûONûTHEûCOVERûOFû+EROSSûlLING

+EROSûRAISEDû53MûPRIVATELYûLASTûMONTHû

ATû53ûAûSHAREûSLIGHTLYûBELOWûTHEû)0/û

MARKETINGûRANGEû4HISûCOULDûHELPûTOû

DIMINISHûANYûPERCEPTIONSûTHATûBYûGOINGû

PUBLICûINûCURRENTûMARKETûCONDITIONSûITûISû

DESPERATEûFORûFUNDING

7ITHûTHEû)0/ûPROCEEDSû+EROSûWOULDûBEû

LEFTûWITHûABOUTû53MûOFûCASHûTOûHELPû

FUNDûDRUGûDEVELOPMENTûINCLUDINGû0HASEû))û

TRIALSûFORûITSûTREATMENTûFORûLOWûBLOODûCELLû

COUNTSûINûPATIENTSûWITHûMYELODYSPLASTICû

SYNDROMESûANDûMYELOlBROSIS

4HEû)0/ûTERMSûATTRIBUTEû+EROSûAûMARKETû

CAPITALISATIONûOFûAROUNDû53M

+EROSûFOLLOWSûITSûFELLOWûBIOTECHû:ENTALISû

0HARMACEUTICALSûWHICHûRAISEDû53Mû

FROMûANûUPSIZEDû)0/ûONû4HURSDAYûUSINGûTHEû

SAMEûVIRTUALûMARKETINGûSTRATEGYûASIDEûFROMû

ONEûNOTABLEûDIFFERENCEû

4HEûCONCENTRATIONûOFûROADSHOWSûINTOûFOURû

ORûlVEûDAYSûOFûVIRTUALûMARKETINGûCERTAINLYû

ALLOWSûMOREûWORKûTOûGETûDONEûINûAûSHORTERû

AMOUNTûOFûTIMEû

)TûCANûALSOûREMOVEûEXPOSUREûTOûTHEû

WEEKENDûHEADLINESûABOUTûTHEûCORONAVIRUSûIFû

TIMEDûPROPERLY

h:ENTALISûTOOKûWEEKENDûHEADLINEûRISKûOFFû

THEûTABLEûBYûLAUNCHINGûONû-ONDAYûFORû

PRICINGûONû4HURSDAYvûANû%#-ûBANKERûTOLDû

)&2ûh7HICHûISûWHYû)ûDONTûUNDERSTANDûTHEû

POINTûOFû+EROSûLAUNCHINGûONû7EDNESDAYv

INVITAE RAISES US$160m OVERNIGHT

INVITAEûAûMAKERûOFûGENETICûTESTSûFORûINHERITEDû

DISEASESûSUCHûASûMUSCULARûDYSTROPHYû

REPLENISHEDûITSûCASHûRESERVESûWITHû53Mû

FROMûANûUPSIZEDûOVERNIGHTûSTOCKûSALEûLASTûWEEK

#ONlDENTIALûMARKETINGûISûAûSTANDARDû

PRACTICEûINû53û%#-ûWHILEûTHEûCORONAVIRUSû

RAGESûONû)NVITAEûPRUDENTLYûDISCUSSEDûITSû

FUNDINGûPLANSûINûPRIVATEûWITHûSELECTû

INVESTORSûONû7EDNESDAYûBEFOREûLAUNCHINGû

THEûDEALûPUBLICLYûONûANûOVERNIGHTûBASIS

JP Morgan and Cowen WEREûABLEûTOûPRICEûANû

UPSIZEDûOFFERINGûOFûMûSHARESûATûAû53û

lXEDûPRICEûVERSUSûTHEû53MûTHATûWASû

TARGETEDûWHENûTHEûDEALûmIPPEDûTOûTHEûPUBLIC

4HEûOFFERûWASûAûHEFTYûûDISCOUNTûTOûTHEû

53ûLASTûSALEûONûTOPûOFûAûûSELL

OFFûINû

)NVITAEûSHARESûONû7EDNESDAY

4HEûSTOCKûPRICEûRECOVEREDûDURINGû

4HURSDAYSûAFTERMARKETûTOûAû53ûlNISHû

AûûRETURNûONûTHEûOFFERûPRICE

)NVITAEûWHICHûSOLDûûOFûOUTSTANDINGûONû

THEûOFFERINGûISûUSINGûSOMEûOFûTHEûPROCEEDSû

TOûFUNDûRECENTûACQUISITIONS

4HEûCOMPANYûSPENTû53MûOFûCASHûONû

THREEûACQUISITIONSûLASTûMONTHûASûWELLûASû

STOCKûCONSIDERATIONûTHATûTOOKûTHEûOVERALLû

VALUEûOFûTHEûPURCHASESûTOû53M

)NVITAEûEXPECTSûTOûREPORTû53MûOFû

REVENUESûFORûTHEûlRSTûQUARTERûOFûûAûû

INCREASEûOVERûTHEûCORRESPONDINGûPERIODûLASTû

YEARûANDûBEATINGûANALYSTSûMEANûESTIMATESû

BYûûACCORDINGûTOû2ElNITIVûDATA

,IKEûMOSTû53ûCOMPANIESû)NVITAEûHASû

WITHDRAWNûFULL

YEARûGUIDANCEûFORûû

BECAUSEûOFûTHEûCORONAVIRUS

)NVITAEûSAIDûITûEXPECTEDûTOûBURNûTHROUGHû

LESSûTHANû53MûOFûCASHûTHISûYEARû4HEû

PROCEEDSûITûRAISEDûLASTûWEEKûPROVIDEû

SUFlCIENTûFUNDINGûFORû)NVITAEûTHROUGHûTOû

ûACCORDINGûTOûAû#OWENûRESEARCHûNOTE

NEVRO PRICES US$301m IN TWO PARTS

NEVROûAûMAKERûOFûSURGICALûIMPLANTSûFORû

CHRONICûPAINûTOOKûSOMEûPREVENTATIVEû

MEDICINEûBYûRAISINGû53MûFROMû

CONCURRENTûOFFERINGSûOFûCOMMONûSTOCKûANDûAû

CONVERTIBLEûBONDû

4HEûISSUERûTOOKûTHEûEFFORTûTOûPRIVATELYû

DISCUSSûTHEûTWO

PARTûlNANCINGûFORûTWOûDAYSû

BEFOREûmIPPINGûTOûTHEûPUBLICûONû7EDNESDAYû

NIGHT

International Financing Review April 4 2020 105

EQUITIES AMERICAS

GLOBAL CONVERTIBLE OFFERINGS

BOOKRUNNERS: 1/1/2020–31/3/2020

Managing No of Total Share

bank or group issues US$(m) (%)

Including exchangeables and domestic offerings.

Source: Refinitiv SDC code: C9

1 Goldman Sachs 12 3,281.31 12.9

2 BofA Securities 10 3,109.75 12.2

3 JP Morgan 14 3,045.44 12.0

4 Morgan Stanley 12 2,531.85 10.0

5 Barclays 5 1,171.71 4.6

6 Citigroup 6 1,167.55 4.6

7 Wells Fargo 2 848.86 3.3

8 BNP Paribas 3 701.80 2.8

9 CICC 3 701.63 2.8

10 Citic 4 665.08 2.6

Total 74 25,435.11

GLOBAL CONVERTIBLE OFFERINGS – US

BOOKRUNNERS: 1/1/2020–31/3/2020

Managing No of Total Share

bank or group issues US$(m) (%)

Source: Refinitiv SDC code: C9a

1 Goldman Sachs 9 2,665.53 23.1

2 BofA Securities 8 2,646.86 22.9

3 JP Morgan 7 1,702.20 14.7

4 Morgan Stanley 7 1,293.03 11.2

5 Wells Fargo 2 848.86 7.3

6 Barclays 3 693.33 6.0

7 Jefferies 2 248.75 2.2

8 Truist Financial Corp 2 151.36 1.3

=8 Citigroup 2 151.36 1.3

10 RBC 1 150.00 1.3

Total 20 11,557.98

GLOBAL CONVERTIBLE OFFERINGS – EMEA

BOOKRUNNERS: 1/1/2020–31/3/2020

Managing No of Total Share

bank or group issues US$(m) (%)

Including exchangeables.

Source: Refinitiv SDC code: C09d

1 JP Morgan 4 917.46 21.8

2 Morgan Stanley 3 751.80 17.8

3 BNP Paribas 2 501.80 11.9

4 UBS 2 340.86 8.1

5 HSBC 1 278.38 6.6

=5 Barclays 1 278.38 6.6

=5 UniCredit 1 278.38 6.6

=5 Citigroup 1 278.38 6.6

9 VTB Capital 1 250.00 5.9

=9 Goldman Sachs 1 250.00 5.9

Total 6 4,216.28

ALL INTERNATIONAL ASIAN CONVERTIBLES

BOOKRUNNERS: 1/1/2020–31/3/2020

Managing No of Total Share

bank or group issues US$(m) (%)

Including exchangeables.

Source: Refinitiv SDC code: M10

1 Citigroup 3 737.81 17.9

2 Morgan Stanley 2 487.03 11.8

3 JP Morgan 3 425.78 10.3

4 BofA Securities 1 372.03 9.0

5 Goldman Sachs 2 365.78 8.9

6 Credit Suisse 4 359.48 8.7

7 UBS 2 315.78 7.6

8 HSBC 2 225.78 5.5

9 Barclays 1 200.00 4.8

=9 BNP Paribas 1 200.00 4.8

Total 9 4,130.06

ALL INTERNATIONAL ASIAN CONVERTIBLES

(EXCLUDING JAPAN)

BOOKRUNNERS: 1/1/2020–31/3/2020

Managing No of Total Share

bank or group issues US$(m) (%)

Including exchangeables.

Source: Refinitiv SDC code: M11

1 Citigroup 3 737.81 19.0

2 Morgan Stanley 2 487.03 12.5

3 JP Morgan 3 425.78 11.0

4 BofA Securities 1 372.03 9.6

5 Goldman Sachs 2 365.78 9.4

6 UBS 2 315.78 8.1

7 Credit Suisse 2 265.00 6.8

8 HSBC 2 225.78 5.8

9 Barclays 1 200.00 5.1

=9 BNP Paribas 1 200.00 5.1

Total 6 3,884.98

10 IFR Equities and SE 2327 p 95 - 106 .indd 105 03 / 04 / 2020 20 : 40 : 34